Suppr超能文献

利斯的明不改变可卡因引起的主观效应或自身给药。

Rivastigmine does not alter cocaine-induced subjective effects or self-administration.

机构信息

Baylor College of Medicine, Menninger Department of Psychiatry, Houston, TX, United States of America.

Baylor College of Medicine, Menninger Department of Psychiatry, Houston, TX, United States of America.

出版信息

Pharmacol Biochem Behav. 2019 Oct;185:172758. doi: 10.1016/j.pbb.2019.172758. Epub 2019 Aug 17.

Abstract

BACKGROUND

Acetylcholinergic (ACh) neurons interface with the mesolimbic dopamine pathway implicated in addiction, and acetylcholinesterase inhibitors (AChEis) have been shown to reduce the immediate effects of cocaine and amount used. Our study is the first to examine if the safe and low-interaction AChEi rivastigmine (riv) alters the subjective effects produced by cocaine administration.

METHODS

Cocaine-dependent subjects were randomized to daily placebo, riv 3 mg, or riv 6 mg, administered inpatient for 10 days. On day 1 (pre-dose) and day 9, subjects received both IV cocaine 40 mg or placebo in a randomized order with subsequent serial assessments of visual analog scale (VAS) subjective effects and pharmacokinetic measurements. On day 10 all participants received one baseline dose of cocaine 20 mg with assessment of subjective effects, and were then able to purchase additional doses at 15 min intervals with study earnings.

RESULTS

40 subjects were randomized to placebo (n = 16), riv 3 mg (n = 13), or riv 6 mg (n = 12). All subjects completed the study and there were no demographic differences between treatment groups. Pre- and post- treatment, there were no significant pharmacokinetic differences (blood levels of cocaine, BE, EME) following cocaine administration. In a two-way ANOVA, IV cocaine significantly increased positive VAS category ratings compared to placebo, but rivastigmine treatment at either dose had no significant effect on any VAS category ratings. Similarly, there was no significant rivastigmine effect on any category in the day 10 cocaine administration, and no effect on number of subsequent doses participants purchased.

CONCLUSION

Rivastigmine 3 or 6 mg had no significant effect on the subjective effects of cocaine after 9 days of treatment. This is an important finding as other drugs in the AChEi class (donepezil, Huperzine A) have produced significant results, but differ in their receptor specificity and PK parameters.

摘要

背景

乙酰胆碱能(ACh)神经元与中脑边缘多巴胺通路相互作用,该通路与成瘾有关,已证明乙酰胆碱酯酶抑制剂(AChEis)可减少可卡因的即时影响和使用量。我们的研究首次检查了安全且低相互作用的 AChEi 加兰他敏(riv)是否会改变可卡因给药产生的主观影响。

方法

可卡因依赖者随机分为每天安慰剂、riv 3mg 或 riv 6mg,住院治疗 10 天。在第 1 天(预剂量)和第 9 天,受试者以随机顺序接受 IV 可卡因 40mg 或安慰剂,随后连续评估视觉模拟量表(VAS)的主观效应和药代动力学测量值。在第 10 天,所有参与者接受一次基线剂量的 20mg 可卡因,并评估主观效应,然后可以以 15 分钟的间隔用研究收入购买额外剂量。

结果

40 名受试者随机分为安慰剂(n=16)、riv 3mg(n=13)或 riv 6mg(n=12)。所有受试者均完成了研究,治疗组之间无人口统计学差异。在给予可卡因后,两种药物治疗均未导致药代动力学显著差异(可卡因、BE、EME 的血药水平)。在双因素方差分析中,与安慰剂相比,IV 可卡因显著增加了阳性 VAS 类别评分,但 riv 加兰他敏治疗在任何剂量下均对任何 VAS 类别评分无显著影响。同样,在第 10 天给予可卡因时,riv 加兰他敏对任何类别均无显著影响,对参与者随后购买的剂量也无影响。

结论

在 9 天的治疗后,rivastigmine 3 或 6mg 对可卡因的主观影响没有显著影响。这是一个重要的发现,因为 AChEi 类中的其他药物(多奈哌齐、石杉碱甲)已产生显著效果,但在受体特异性和 PK 参数方面存在差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验